HYTN Innovations Inc (HYTN) AI Stock Analysis

• Market Cap: C$14.06M
• Dividend Yield: N/A
• Average Volume (3M): 7.58K
• Price to Earnings (P/E): ―
• Beta (1Y): -3.33
• Revenue Growth: 68.80%
• EPS Growth: -204.31%
• Country: CA
• Employees: 7
• Sector: Technology
• Sector Strength: 91
• Industry: Beverages - Alcoholic
• EPS (TTM): >-0.01
• Shares Outstanding: 93,708,110
• 10 Day Avg. Volume: 4,503
• 30 Day Avg. Volume: 7,585
• PEG Ratio: -0.85
• Price to Book (P/B): -35.84
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -15.88
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 38 Underperform
• Price Target: C$0.00 ▼(-100.00%Downside)

HYTN Innovations Inc. faces significant financial challenges, reflected in its low financial performance and valuation scores. Technical analysis suggests a potential for price stabilization, while recent corporate events show promise in expanding market reach. However, these positives currently do not offset the financial risks.

HYTN Innovations Inc Business Overview & Revenue Model

Company Description

HYTN Innovations Inc. engages in the research, production, marketing, distribution, and sale of cannabis products for recreational consumers in Canada. It intends to offer infused sparkling beverages and infused edibles in various flavors. The company is headquartered in Vancouver, Canada.

How the Company Makes Money

HYTN Innovations Inc makes money primarily through the sale of its cannabis-infused beverage products. The company's key revenue streams include direct sales to consumers through retail channels and partnerships with licensed cannabis retailers and distributors. Additionally, HYTN may generate income through strategic partnerships and collaborations with other companies in the cannabis industry, leveraging its expertise in product development and innovation to expand its market presence and reach.

HYTN Innovations Inc Financial Statement Overview

Summary

HYTN Innovations Inc. is in a difficult financial position with negative profitability and cash flow metrics. The balance sheet shows negative equity, indicating financial instability and potential solvency issues.

Income Statement

HYTN Innovations Inc. has shown some revenue growth, but profitability remains a concern with negative net income, EBIT, and EBITDA margins. The gross profit margin is slightly positive, indicating potential for future improvement, but the net profit margin remains deeply negative.

Balance Sheet

The company's balance sheet shows a negative equity position, indicating financial instability. The debt-to-equity ratio cannot be calculated due to negative equity, and the equity ratio is also negative, highlighting potential solvency issues.

Cash Flow

HYTN's cash flow statement reveals negative free cash flow and operating cash flow, suggesting cash burn. The company relies heavily on financing activities, which may not be sustainable long-term. There is no free cash flow growth, and the ratios to net income are challenging to assess with negative figures.

Breakdown	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2019
Income Statement
Total Revenue	851.49K	763.46K	696.36K	0.00	0.00
Gross Profit	287.44K	91.85K	121.65K	0.00	-1.12K
EBITDA	-6.26M	-1.45M	-9.88M	-745.51K	-310.99K
Net Income	-6.61M	-2.33M	-17.38M	-959.48K	-311.66K
Balance Sheet
Total Assets	2.38M	2.58M	3.79M	2.76M	507.25K
Cash, Cash Equivalents and Short-Term Investments	256.58K	187.56K	1.03M	264.06K	271.16K
Total Debt	793.56K	919.74K	887.22K	2.58M	41.98K
Total Liabilities	2.56M	2.27M	1.71M	2.77M	18.41K
Stockholders Equity	-172.97K	314.72K	2.07M	-8.88K	488.85K
Cash Flow
Free Cash Flow	-804.21K	-1.18M	-2.38M	-1.67M	-409.37K
Operating Cash Flow	-783.36K	-1.18M	-2.16M	-693.52K	-311.08K
Investing Cash Flow	162.67K	-4.10K	2.19M	-1.02M	-98.29K
Financing Cash Flow	689.71K	346.17K	727.93K	1.80M	700.53K

HYTN Innovations Inc Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.15
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:HYTN, the sentiment is Negative. The current price of 0.15 is below the 20-day moving average (MA) of 0.18, below the 50-day MA of 0.20, and below the 200-day MA of 0.25, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 34.02 is Neutral, neither overbought nor oversold. The STOCH value of >-0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:HYTN.

HYTN Innovations Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	63 Neutral	$34.72B	5.19	-11.20%	1.67%	5.59%	-16.73%
LSPK	52 Neutral	$18.92M	―	-549.30%	―	-8.04%	4.04%
BR	47 Neutral	C$24.89M	―	-46.36%	―	9.98%	-80.44%
HYTN	38 Underperform	C$14.06M	―	-9999.00%	―	68.80%	-204.31%
DWS	―	C$13.15M	―	-8.99%	―	―	―
HYPE	―	C$8.28M	―		―	―	―
VDKA.H	―	C$524.89K	―		―	―	―

HYTN Innovations Inc Corporate Events

HYTN Innovations Secures Cannabis Drug Licence, Expanding Pharmaceutical Capabilities

HYTN Innovations Inc. has received a Cannabis Drug Licence (CDL) from Health Canada, enhancing its capabilities to manufacture cannabis-derived pharmaceutical drugs. This positions HYTN among a select group of organizations in Canada authorized for such production, allowing it to expand into the pharmaceutical market. The CDL enables HYTN to support clinical research, pursue drug approvals, and engage in global pharmaceutical supply chains, thereby strengthening its industry positioning. The company’s dual licensing allows it to act as a Contract Development and Manufacturing Organization (CDMO) partner, providing GMP-compliant cannabinoid production and formulation development for clinical-stage biotech and pharmaceutical companies.

HYTN Innovations Secures First International Order for GMP Vape Cartridges

HYTN Innovations Inc. has received its first international purchase order for Good Manufacturing Practices (GMP) cannabis vape cartridges, marking a significant milestone in its collaboration with SNDL. This order, which involves 1000 one-gram live resin vape cartridges, is set to be exported to the United Kingdom, pending permit approvals, and underscores HYTN’s commitment to quality and its capability to serve regulated international markets. This development highlights the company’s growing influence in the global pharmaceutical cannabis market and its dedication to expanding its product portfolio with high-quality GMP cannabis products.